(Q48234353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

4 April 2020

main subject

0 references

mesenchymal stem cell

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Crissy Fellabaum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Vladislav Volarevic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Bojana Simovic Markovic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

C Randall Harrell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Marina Gazdic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Nebojsa Arsenijevic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

1 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

Stem Cell Reviews and Reports

4 April 2020

published in

1 reference

9 February 2018

http://europepmc.org/abstract/MED/29177796

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

153-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Infectious gastroenteritis and risk of developing inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Regulation of homeostasis and inflammation in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Dendritic cells in intestinal homeostasis and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

CD4 T-cell differentiation and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

T-cell-directed therapies in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Regulatory T cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

In vitro differentiation of human mesenchymal stem cells to epithelial lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells can be differentiated into endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Endothelial differentiation of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Human adipose tissue is a source of multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Adipose-Derived Mesenchymal Stem Cells Ameliorate Ulcerative Colitis Through miR-1236 Negatively Regulating the Expression of Retinoid-Related Orphan Receptor Gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Various types of stem cells, including a population of very small embryonic-like stem cells, are mobilized into peripheral blood in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Nonmyeloablative Stem Cell Therapy Enhances Microcirculation and Tissue Regeneration in Murine Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9789-2

Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody

21 January 2018

1 reference

12 December 2020

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1 reference

12 December 2020

Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy

1 reference

12 December 2020

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

1 reference

12 December 2020

Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases

1 reference

12 December 2020

CD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA Interactions

1 reference

12 December 2020

Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats

1 reference

12 December 2020

Immunological properties of umbilical cord blood-derived mesenchymal stromal cells

1 reference

12 December 2020

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses

1 reference

12 December 2020

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

1 reference

12 December 2020

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

1 reference

12 December 2020

Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis

1 reference

12 December 2020

Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease

1 reference

12 December 2020

Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease

1 reference

12 December 2020

Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction

1 reference

12 December 2020

Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications

1 reference

12 December 2020

Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease

1 reference

12 December 2020

10.1007/S12015-017-9789-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29177796%20AND%20SRC:MED&resulttype=core&format=json

release_no77rjvgozh3jlwndnluhmn4hy

4 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/no77rjvgozh3jlwndnluhmn4hy

24 November 2022

mapped directly with Wikidata item

1 reference